Chicago Partners Investment Group LLC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 48 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Chicago Partners Investment Group LLC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2018$0160.0%0.00%
Q2 2018$0160.0%0.00%
Q1 2018$0160.0%0.00%
Q4 2017$0160.0%0.00%
Q3 2017$0160.0%0.00%
Q1 2017$0160.0%0.00%
Q4 2016$0160.0%0.00%
Q3 2016$0160.0%0.00%
Q2 2016$0160.0%0.00%
Q1 2016$0160.0%0.00%
Q4 2015$0160.0%0.00%
Q3 2015$0160.0%0.00%
Q2 2015$0160.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$17,019,0002.88%
Northeast Financial Consultants Inc 732,265$3,368,0001.50%
Family Management Corp 12,008$55,0000.04%
Acrospire Investment Management LLC 6,101$28,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$681,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,901,0000.01%
OXFORD ASSET MANAGEMENT LLP 48,790$224,0000.01%
Parallel Advisors, LLC 3,538$16,0000.00%
Squarepoint Ops LLC 15,690$72,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$69,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders